莎普爱思：二氟尼柳片通过仿制药一致性评价

Core Viewpoint - The company Shapais (603168) has received approval from the National Medical Products Administration for the drug Diflunisal, which is now considered to have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The drug Diflunisal is indicated for the treatment of rheumatoid arthritis, osteoarthritis, and various mild to moderate pain [1]